The Components of Asia-Pacific IMBN

• Members - from among whom representatives on the Governing Council are elected;

• Asia-Pacific IMBN Supporting Institutions which are institutions, public and private, which are committed to the goals and objectives of Asia-Pacific IMBN and which provides financial and in-kind support as specified in the guidelines established by the Governing Council

•  Asia Pacific IMBN Governing Council is the  governance authority.  The Council is expected to operate several committees including a Membership Committee, a Program Committee and a Finance and Resource Mobilization Committee. The Asia-Pacific IMBN Governing Council is responsible for overseeing the establishment of the Asia-Pacific IMBN.  The Governing Council plans to establish Asia-Pacific IMBN  by inter-governmental agreement as this would ensure the strongest levels of commitment and "ownership" of Asia-Pacific IMBN by governments and national funding agencies. 

• The Asia-Pacific IMBN Advisors which consist of prominent leading figures internationally selected because of their individual excellence to  help provide advice and guidance to the Network

• The Asia-Pacific IMBN Support Council in which Asia-Pacific IMBN funders and supporters (including supporting institutions, foundations, government support agencies, and industry sponsors) would be invited to participate to help shape the direction and focus of its activities, to ensure that these are consistent with priority concerns and needs of scientists and institutions in the region, and to provide support (financial and in-kind) for the work of Asia-Pacific IMBN.

• Asia-Pacific IMBN Secretariat is  the action-focused compartment of the organization. This is the primary contact point for parties interested in the aims and activities of Asia-Pacific IMBN

Back to top

Asia-Pacific IMBN Governing Council

Constitution of the Governing Council

An elected Governing Council met for the 1st time in February 1999 in Tsukuba, Japan, and took over governance responsibility for Asia-Pacific IMBN from the Establishment Taskforce. Ken-ichi Arai was elected President of the Governing Council, Louis Lim was elected Vice-President (Organizational Development), Yim Jeongbin Vice-President (Program Development) and Nancy Ip was elected Treasurer. Gurinder Shahi, as Executive Director/Coordinator of the Asia-Pacific IMBN Secretariat, serves as Secretary to the Governing Council.

 The Council agreed to maintain 3 Committees: 

A Membership Development Committee
A Program Committee
A Finance and Resource Mobilization Committee

Membership Development Committee

Chair:  

Warren Tate, Head, Biochemistry Dept., University of Otago, New Zealand

Committee Members

1. Gynheung An, Professor, Dept of Life Science, Pohang University of Science and Technology, Korea

2. William Chia,  Deputy Director (Academic & Research Matters), Institute of Molecular and Cell Biology, Singapore

3. Ashley Dunn, Professor, Ludwig Institute for Cancer Research, Australia

4. Lin Jung Yaw, Professor, Institute of Biochemistry, College of Medicine, National Taiwan University, Chinese Taipei

5. Bernadette Libranda-Ramirez, Vice-Chair (Research), Dept. of Biochemistry and Molecular Biology, University of the Philippines, Philippines

6. Atsushi Miyajima, Professor, Institute of Molecular and Cell Biosciences, University of Tokyo

7. Tikki Pang, Director, Research Policy & Cooperation, Evidence & Information for Policy Cluster, WHO (representing Malaysia)

8. Leo Sachs, Otto Meyerhof of Molecular Biology, Dept. of Molecular Genetics, Weizmann Institute, Israel

9. Obaid Siddiqi, Emeritus Professor, Tata Institute of Fundamental Research, India

10. Harawati Sudoyo, Executive Manager, Eijkman Institute for Molecular Biology, Indonesia

11. Patrick Sullivan, Head, Institute of Molecular BioSciences, Massey University, New Zealand

12. Jisnuson Svasti, Professor, Dept. of Biochemistry, Mahidol University, Thailand

13. Jerry Wang, Head, Dept of Biochemistry, Hong Kong University of Science and Technology, Hong Kong, China

Program Committee

Co-Chairs: 

Yoshikazu Nakamura, Assoc. Prof, Institute of Medical Science, University of Tokyo, Japan

Yim Jeongbin, Prof. Dept of Microbiology, Seoul National University, Korea

Committee Members

1. Amares Bhumiratana, Prof. Dept of Biotechnology, Mahidol University, Thailand

2. Chen Chien-Jen, Prof., Graduate Institute of Epidemiology, National Taiwan University, Chinese Taipei

3. Benjamin Geiger, Head, Dept of Molecular Cell Biology, Weizmann Institute, Israel

4. Koh Chong-Lek, Prof. & Coordinator of Genetics & Molecular Biology, Institute of Biological Sciences, University of Malaya, Malaysia

5. John Mattick, Prof. & Director, Center for Molecular and Cellular Biologym, Australian Genome Research Facility, University of Queensland, Australia

6. Filipinas Natividad, Director, Research and Biotechnology Div., St. Luke's Medical Center, Philippines

7. Catherine Pallen, Assoc. Prof, Institute of Molecular and Cell Biology, Singapore

8. Wong Yung-Hou, Assoc. Prof, Dept. of Biology, Hong Kong University of Science and Technology, Hong Kong, China

Finance and Resource Mobilization Committee

Chair: 

Nancy Ip, Director, Biotechnology Research Institute, Hong Kong University of Science and Technology

Committee Members:

1. Hwang Jaulang, Director, Institute of Molecular Biology, Academic Sinica, Chinese Taipei

2. Katsuro Koike, Chief, Dept. of Gene Research, The Cancer Institute, Japan

3. Alex Levitzki, Wolfson Family Professor of Biochemistry, Dept. of Biological Chemistry, The Alexander Silverman Institute of Life Sciences, Israel

4. Keith Stanley, Deputy Director, Centre for Immunology, St. Vincent's Hospital, Australia

5. Y H Tan, Director, Institute of Molecular and Cell Biology, Singapore

6. Wilfred Tiu, Professor, Dept. of Parasitology, College of Public Health, University of the Philippines, Philippines

7. James Watson, CEO, Genesis Research and Development Corporation Limited, New Zealand. 

8. Ook Joon Yoo, Director, Biomedical Research Center, Korea Advanced Institute of Science and Technology, Korea

9. Zulkeflie Zamrod, Lecturer, Dept. of Genetics and Centre for Gene Analysis and Technology, University Kebangsaan Malaysia, Malaysia

Back to top

Asia-Pacific IMBN Advisors

Asia-Pacific IMBN is proud to have distinguished scientists as our advisors. 

• David Baltimore*, President, California Institute of Technology, USA

• Paul Berg*,  Director, Stanford University, School of Medicine, USA

• Sydney Brenner, Director, The Molecular Sciences Institute, USA

• Frank Gannon,  Executive Director, European Molecular Biology Organization, Germany

• Marianne Grunberg-Manago, Emeritus Director of Research, French National Research Council, Institute de Biologie, Physico-Chimque, France

• Tasuku Honjo, Dean, School of Medicine, Kyoto University, Japan

• Robert Huber*, Abteilung Structurforschung, Max-Planck-Institute fur Biochemie, Germany

• Fotis C. Kafatos, Director General, European Molecular Biology Laboratories, Germany

• Gobind Khorana*, Department of Biology and Chemistry, Massachusetts Institute of Technology

• Arthur Kornberg*, Stanford University, Medical Center, USA

• Richard M. Krause, Senior Scientific Advisor, Fogarty International Center, National Institutes of Health, USA

• Arthur Levine, Senior Vice Chancellor, School of Medicine, University of Pittsburg, USA

• Maciej J. Nalecz, Director, The Nencki Institute of Experimental Biology, Polish Academy of Sciences, Poland

• Gustav Victor Nossal, Prof. Emeritus, Department of Pathology, University of Melbourne, Australia

• Michael Sela, President of the Scientific Council, Institut Pasteur-Weizmann Institute, Israel

* Nobel Laureate